These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17171924)

  • 1. Efficacy of enoximone in the management of refractory low-output states following cardiac surgery.
    Gonzalez M; Desager JP; Jacquemart JL; Chenu P; Muller T; Installé E
    J Cardiothorac Anesth; 1988 Aug; 2(4):409-18. PubMed ID: 17171924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of enoximone and dobutamine on hemodynamic performance after open heart surgery. A clinical comparison.
    Zeplin HE; Dieterich HA; Stegmann T
    J Cardiovasc Surg (Torino); 1990; 31(5):574-7. PubMed ID: 2146272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of a new inotropic agent, enoximone, in heart surgery].
    Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA
    Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dobutamine and enoximone for low output states following cardiac surgery.
    Orellano L; Darwisch M; Dieterich HA; Köllner V
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S13-9. PubMed ID: 2145233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of enoximone versus tobutamine in the treatment of low cardiac output after cardiac surgery].
    Lançon JP; Caillard B; Volot F; Obadia JF; Bock F
    Ann Fr Anesth Reanim; 1990; 9(3):289-94. PubMed ID: 2142589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of enoximone in the management of refractory low output states following cardiac surgery.
    Gonzalez M; Desager JP; Jacquemart JL; Chenu P; Muller T; Installé E
    Br J Clin Pract Suppl; 1988 Dec; 64():53-64. PubMed ID: 2978501
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-output syndrome after heart surgery: is a monotherapy with phosphodiesterase-III inhibitors feasible? A comparative study of amrinone and enoximone.
    Zerkowski HR; Günnicker M; Freund U; Dieterich HA; Dressler HT; Doetsch N; Schieffer M; Hakim-Meibodi K; Lockhart JD; Reidemeister JC
    Thorac Cardiovasc Surg; 1992 Dec; 40(6):371-7. PubMed ID: 1290186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension.
    Hachenberg T; Möllhoff T; Holst D; Hammel D; Brüssel T
    J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):453-7. PubMed ID: 9187994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoximone versus epinephrine/nitroglycerin in cardiac low-output states following valve replacement.
    Zwölfer W; Dressler HT; Keznickl P; Dieterich HA
    Clin Cardiol; 1995 Mar; 18(3):145-9. PubMed ID: 7743685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart.
    Gilbert EM; Hershberger RE; Wiechmann RJ; Movsesian MA; Bristow MR
    Chest; 1995 Dec; 108(6):1524-32. PubMed ID: 7497755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enoximone in postoperative "low-output syndrome"--comparison with dobutamine].
    Orellano L; Darwisch M; Dieterich HA; Köllner V
    Z Kardiol; 1991; 80 Suppl 4():53-7. PubMed ID: 1833898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with phosphodiesterase inhibitors in paediatric cardiac surgery.
    Hausdorf G
    Eur J Anaesthesiol Suppl; 1993; 8():25-30. PubMed ID: 8223352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous infusion of enoximone in the treatment of acute myocardial ischemia with low output syndrome].
    Sicignano A; Bellato V; Riboni A; Vesconi S
    Minerva Anestesiol; 1994 Mar; 60(3):109-13. PubMed ID: 8090300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of low cardiac output syndrome after cardiac surgery using enoximone.
    White DA; Latimer RD; Oduro A
    Anaesthesia; 1990 May; 45(5):386-9. PubMed ID: 2141451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects and comparison of enoximone, dobutamine and dopamine following mitral valve surgery.
    Tarr TJ; Moore NA; Frazer RS; Shearer ES; Desmond MJ
    Eur J Anaesthesiol Suppl; 1993; 8():15-24. PubMed ID: 8223351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
    Holubarsch C; Pieske B; Hasenfuss G; Just H
    Z Kardiol; 1994; 83 Suppl 2():21-5. PubMed ID: 8091821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of phosphodiesterase inhibitor enoximone in management of postcardiotomy cardiogenic shock.
    Iversen S; Mayer E; Hake U; Schmiedt W; Jakob H; Oelert H
    Scand J Thorac Cardiovasc Surg; 1992; 26(2):143-9. PubMed ID: 1439645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of enoximone in the treatment of cardiogenic shock.
    Vincent JL; Léon M; Berré J
    Cardiology; 1990; 77 Suppl 3():21-6; discussion 27-33. PubMed ID: 2176130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of enoximone in weaning from cardiopulmonary bypass following mitral valve surgery.
    Tarr TJ; Jeffrey RR; Kent AP; Cowen ME
    Cardiology; 1990; 77 Suppl 3():51-7; discussion 62-7. PubMed ID: 2148281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of acute low cardiac output syndrome after surgery of congenital heart defects: value of enoximone].
    Schranz D; Bauer J; Wiemann J; Kühl G; Dapper F; Wippermann CF; Huth R; Oelert H
    Z Kardiol; 1994; 83 Suppl 2():83-9. PubMed ID: 8091830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.